chrisvoncsefalvay/vaers-outcomes huggingface dataset:
noticed swollen lymph node after 1 week, was smaller but still noticeable; This is a spontaneous report from a contactable other HCP (patient).  A 34-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 06Apr2021 10:00 (Lot number: Er8730) at the age of 34 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Allergic to pears" (unspecified if ongoing). There were no concomitant medications. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 13Apr2021, outcome "not recovered", described as "noticed swollen lymph node after 1 week, was smaller but still noticeable". Therapeutic measures were not taken as a result of lymphadenopathy. Additional information: the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 before vaccination. Post-Vaccination COVID-19 test was not done.  No follow up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021486668 same drug/reporter/patient, different dose (2nd dose)
Full, all-over body pain on the skin, face, hands, feet, legs; Chills; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration at unknown site on 07Apr2021 at 12:30 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The  patient did not have any relevant medical history. Concomitant medications were not reported. The patient had no known allergies. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration at unknown site on 17Mar2021 at 12:00 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 08Apr2021 at 01:00, reportedly experienced full, all-over body pain and soreness everywhere from the tip of fingers and toes to the back and neck. Cannot rest or lay on back due to pain in contact with any surface (it was very painful even without contact). It was almost 24 hours after receiving the vaccine and the pain was still as bad as it was last night. The chill has gone away though, but she was complaining of the pain that ADVIL seems not to be able to provide any relief. Therapeutic measures were taken as a result of adverse event pain which included treatment with ADVIL. The adverse events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. The clinical outcome of the event chills was recovered on 08Apr2021, all-over body pain on the skin, face, hands, feet, legs was not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medication were not provided. On 08-SEP-2016, the patient was vaccinated with improperly stored PNEUMOVAX 23 (lot # L019835, expiration date 23-MAR-2016; dose and route were unknown). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt recvd vax;on 1oct95 varicella antibody titer was neg at .75;on 11oct95 titer neg at ,56;
Vaccine administered on 12/16. Patient reported that her face and chest became flushed that evening. The next day she noticed bruising with some induration at injection site with some arm swelling. She said she had a rash develop on 12/20 that lasted for a day.
Information has been received from a consumer, who is the patient's mother, concerning a 15 year old female who in September 2007, was vaccinated with the first dose of GARDASIL (lot# not reported). Concomitant therapy included meningococcal vaccine (unspecified). Per the mother, the patient experienced a headache after receiving the first dose. The patient recovered from her headache. In November 2007, the patient was vaccinated with he second dose of GARDASIL (lot# not reported). Again, the patient experienced headache after receiving the second dose. In March 2008, the patient was vaccinated with a third dose of GARDASIL (lot# not reported) and the patient started to experience a headache that lasted for 3 weeks. The patient also developed chest pain that she is still experiencing until today. The patient was brought to the ER on 08-APR-2008, but was not admitted to the hospital. The mother mentioned that the patient was absent from school 10 days last month because of the symptoms. No further information was provided. Additional information has been requested.  5/29/08 Reviewed ER medical records of 4/2008.  FINAL ER Dx: atypical chest pain  Records of 4/8/08 visit for chest pain, HA & left arm pain intermittently x 1 mo.  Had vertigo since last HPV vax on 3/17/08.  6/3/08 Reviewed PCP medical records & vaccine records.  Patient received HPV #1 0960F on 9/11/2007 unknown site; HPV #2 1266U on 11/16/2007 LUE; HPV #3 1486U on 3/17/2008 LUE.  Nausea, dizziness, HA day after 1st HPV.  On 3/11/08 woke w/heart racing, sharp chest pain & dizziness.  On antibiotic at that time for strep throat dx 3/6/08.  Referred to peds cardio.  On 3/18, parent reported dizziness & nausea day after each HPV vaccine.  Cardio consult 3/15/08 WNL.  07/08/08 This is in follow-up to report(s) previously submitted on 4/14/2008. Information has been received from a health professional concerning a 15 year old female student with chest pain and a viral infection at the time of vaccination, who on 17-Mar-2008 was vaccinated IM in the left deltoid with 0.5 ml third dose of GARDASIL (lot# 659655/1486U). The patient had received all three doses. After each dose the patient developed weakness, dizziness and fainting. Unknown medical attention was sought. At an unknown date the patient recovered. No PQC involved. Follow up information received fromthe patient's mother indicated that the patient experienced episodes of dizziness and nausea after all three doses lasting 1 to 2 days begins day after immunization. She had missed school due to this. Follow up information received from the mother again indicated that on 11-Sep-2007, the patient was vaccinated with her first dose of GARDASIL (lot# 654535/0960F) into the right arm and on 16-Nov-2007 with the second dose of GARDASIL (lot# 659437/1266U) into the left arm. After each dose the next 2 days had dizziness, fatigue enough not to be able to attend school. She had nausea too. The patient has recovered. Additional information has been requested.
Pt received vaccine with mother present at 1419, c/o dizziness, lightheadedness, blurry vision, difficulty hearing, at 1439.  Pt states she did not eat lunch.  Nursing team intervened by taking vitals, placing wet towel on forehead, lying pt in supine position with legs elevated.  Pt VS stable, pulse in 80s, BP(120s/80s), 99% on RA, RR 16-18, no respiratory distress, no s/sx anaphylaxis.  Pt states she did not eat lunch.  Gatorade offered to pt.  Dizziness improves in supine position but returns upon sitting.  At 1532 pt states she has facial numbness.  EMS called at 1535.  EMS arrived at 1557 and assessed pt.  Pt?s BG is 93, VS stable.  Pt reports feeling dazed, unable to focus, blurry vision and difficulty hearing.  At 1602 EMS informed pt that they will take her to Medical Center, pt immediately got agitated and started crying and hyperventilating.  1604 pt stated she had difficulty breathing and a light localized rash began to appear on her chest.  1605 EMS transported pt.  Pt?s mother to follow.
injection site pain, tiredness, severe headache, muscle pain, chills, injection site swelling, nausea, not feeling myself, difficulty breathing, fast heartbeat, dizziness and weakness in lower extremity and excruciating lower back pain.    Immediately after vaccine was given, I got the side affects. Felt a little better for 2-3 hours and then it hit me hard again and lasted till the next day. Currently my arm is swollen.
Moderna 5/15/21, 8/6/21. Positive on 12/30/22
From his 1ST dose he had soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (From his 1ST dose he had soreness in arm) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02SB21A or 025B21A and 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (From his 1ST dose he had soreness in arm) (seriousness criterion hospitalization). At the time of the report, MYALGIA (From his 1ST dose he had soreness in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Company comment-Based on the current available information and temporal association between the use of the product and the start date of the events noted in the narrative of the RA, a causal relationship cannot be excluded.  Relevant concomitant medications were not reported.  Treatment information was not provided.   This case was linked to MOD-2021-277714 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow-up received : dose regimen for first dose and second dose added. lot number added for both dosage.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events noted in the narrative of the RA, a causal relationship cannot be excluded.
sore arm; slight fever that was short lived; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and PYREXIA (slight fever that was short lived) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and PYREXIA (slight fever that was short lived). At the time of the report, PAIN IN EXTREMITY (sore arm) and PYREXIA (slight fever that was short lived) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  No treatment information was not provided.
3 days p/vax the site became a hard ball, then red & itching to 6.5 x 7.5 of erythema w/2x3 cm center of darker red color;
Pt received DPT #2, IPV #2, HIB #2, Hep B #3, Prevnar #2 on 9/10/03. Left leg swollen with knot and red at injection site. Hib #2, Hep B #3 given in left leg.
This spontaneous report received from a medical assistant referred to a 4 year old female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. The patient was administered first dose of VARIVAX 0.5 ml subcutaneously on 20-NOV-2013, second dose on 19-NOV-2015 and third dose on 12-DEC-2016 (lot: M023495, expiry: 06-JUL-2018) (extra dose administered). No adverse effects were reported. Additional information has been requested.
heat at the injection site; little bump at injection site; Soreness at the injection site; redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (heat at the injection site), VACCINATION SITE MASS (little bump at injection site), VACCINATION SITE PAIN (Soreness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 027B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (heat at the injection site), VACCINATION SITE MASS (little bump at injection site), VACCINATION SITE PAIN (Soreness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site). At the time of the report, VACCINATION SITE WARMTH (heat at the injection site), VACCINATION SITE MASS (little bump at injection site), VACCINATION SITE PAIN (Soreness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site) outcome was unknown. Not Provided          Patient reported that events appeared 3 days after receiving second dose of vaccine. Action taken with mRNA-1273 in response to the events was not Applicable.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received on 25-May-2021, no significant information updated
Both vaccines were given in left arm.  I felt zero pain from the COVID vaccine.  The flu vaccine was given very high up on my arm, almost on top of my shoulder.  I felt immediate pain and heaviness in the left arm.  Ever since, I have sharp shooting pain in the top of my arm, my shoulder and the left side of my neck.  I have been waiting for it to go away, but it won't.  I have difficulty sleeping due to the shoulder/arm/neck pain.  I wonder if the injection hit a nerve?  I will see my doctor on 12/09/22, this is her first available appointment.
After vaccine noticed that eve. arm swollen painful - golf size red area at site - woke in night with fever, sweating. Fever 99 later - checked with pt daily - area improving each day 6/28/11 - Area clear no issues reported.
Pt was immunized on 3-4-10. On 3-6-10, pt was seen by MD after developing fever (103), redness, swelling and pain in the left upper arm. MD diagnosed immunization reaction and prescribed cephalexin, cool compress and BENADRYL.
25JUN91 mom said child looked pale on day of shot cried alot; said on several occasions I don't feel well- I want to vomit; Knot on arm 1/2 dollar size;
Report 2000035167-1 describes possible cutaneous T-cell lymphoma in a male (age not provided) who received an injection of hepatitis-b vaccine (brand name unknown). This report was received from the patient's father and has been confirmed by a physician.  Concurrent medical conditions and medications were not provided. A male received two doses of a hepatitis-b vaccine (brand name and dates of administration unknown). At some later, unspecified date, the patient was seen by a dermatologist. The dermatologist referred the patient for diagnosis and treatment to another dermatologist at a tertiary-care center. Results of a biospy performed by the second dermatologist "were not clear". A tentative diagnosis of possible cutaneous T-cell lymphoma was made. The first dermatologist reported that, in the absence of a definitive diagnosis, she considers this event to be possibly related to the administration of hepatitis b vaccine. She stated that, to her knowledge, the patient had not been hospitalized and was not disabled by this event.
This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. Medical history included cancer (unspecified if ongoing). Concomitant medications not reported. The patient experienced dizziness and nausea, with outcome of unknown. Additional information: The patient's mother had both shots and experienced side effects for about two weeks from the first shot, but not as long or as bad for the second shot. She didn't have chest pain or want to pass-out. She had dizziness and nausea. When ask to make a separate report on herself, she stated she will call back later on herself. This is a clone report created to document the caller's experience. Primary/Prescriber: not provided. Product: Pfizer COVID-19 vaccine; no NDC, lot or expiration date provided. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected. Sender's comments: Linked report(s): US-PFIZER INC-2021567769 same reporter/product, different patient/event.
Rash and tinnitus reaction after receiving tetanus injection. No reaction at the site of TD injection. Rash under breast, on back and legs.
Fever 104, altered consciousness, dyspnea, chills on 1/9/05. Vaccines given 1/6/05. Blood, CSF, Urine cultures, IV fluids, IV Rocephin one dose in ER. Follow up 02/03/2005: Diagnosis: Fever no focus, R/o Bacteremia, altered mental status. Physician's letter requesting financial help.
Mother called and stated child with left arm swelling and pain. Mother applied cold compress w/ ice to site. Redness, edema and tenderness on site.
Woke in the middle of the night following vaccines passed out with loff of bladder control.
I had no difficulty after receiving the vaccine. I was exposed to COVID-19 in an airplane. I started feeling symptoms of congestion on 12/01/2022. I tested positive for COVID-19 on 12/02/2022. I contacted my doctor, and I was advised to take pain reliever as needed and I was given supplements to help with my symptoms.
No adverse effects.  Pt was vaccinated 3 days prior to turning 18 years of age, which is the recommended age for administration.
Patient was exposed to a child in daycare who had chickenpox on 9/26/11, patient also had her VARIVAX vaccine on 9/26/11. 10/8/11 she started with a fever of 102 & runny nose, awoke 10/10 with apparent chicken pox on her trunk, # of pox increased through AM. On 10/11 spots spread to neck no vesicles yet.
Covid + 1/17/22, admitted to Hospital with worsening shortness of breath. Hypoxic on room air
This spontaneous report was received from a physician referring to an 18 year old male patient. The patient had no relevant medical history and was not taking any concomitant medications. He had no known drug reactions or allergies. Concurrent conditions were not reported. On 14-JUN-2017, the patient was vaccinated with the first dose of GARDASIL 9 intramuscularly, for prophylaxis (dosage not reported; lot # N001533, expiration date 16-OCT-2019). Other suspect medications included MENACTRA, with which the patient was vaccinated on the same date. About a minute after the vaccines were administered, the patient experienced a seizure-like episode: he leaned backwards from a sitting position to being flat and exhibited upper body stiffening and he stared unresponsively. The event lasted about 10 seconds in total. The patient did not receive treatment for the event and he recovered on the same day. The reporter did not provide an assessment on the causal relationship between the event seizure like phenomena and therapy with GARDASIL 9. Upon internal review, the event seizure like phenomena was considered to be medically significant. Additional information has been requested.
Client states she felt a slight tingling in her lips on her drive home. She took Zyrtec 10mg @ HS. In AM had Silver dollar size lump at vaccine site which was red and warm to touch. States she had itching on her face and back and took Benadryl 25 mg and Zyrtec 10mg which relieved most of her symptoms. States she still has a little bit of itching and the lump has gone down in size.
PC from MD stating pt seen 30OCT92 w/c/o itching/rash started 28OCT92 urticaria given DPH cream by MD-taking Pred; has rash on breast, neck, peri area, buttocks, lt arm antecubital area, erythema edema;
Severe itching & redness of palms of both hands & the soles of both feet. Constant itching. Started on Saturday. Progressively got worse. Very mildly relieved by Benadryl.  Itching started to MILDLY migrate to other parts of the body, but remained constant & severe in the palms & soles of feet.
Fever; aches; Trigger finger in right thumb day after 1st vaccine, worse after 2nd vaccine; This is a spontaneous report from a contactable consumer (patient reported herself). A 67-year-old non-pregnant female patient received second dose of BNT162B2 (COVID 19, Pfizer, Formulation: Solution for injection, Lot number: EL9261) via an unspecified route of administration to her right arm on 18Feb2021 09:00 AM at single dose for Covid-19 immunization. The patient's medical history included mild asthma. Known allergies: None. Historical vaccine details included first dose of BNT162B2 (COVID 19, Pfizer, Lot number: EL8982, Expiration date: May2021) via an unspecified route of administration to her right arm on 28Jan2021 16:30 PM at single dose for Covid-19 immunization. Concomitant medications (other medications in two weeks) included levothyroxine and meloxicam. On an unspecified date in Feb2021 21:00 PM, the patient experienced trigger finger in right thumb day after first vaccine, worse after second vaccine fever and aches day after second vaccine fever for seven hours five days after vaccine. The patient did not receive any treatment in response to the events. Outcome of the events was recovering.
Narrative:  COVID infection following COVID vaccine series 02/11, Moderna , dose #1 03/11, Moderna , dose #2 08/29 pt cc: chills, cough, fever, headache, fatigue, rhinorrhea, myalgias, exposure:  friend 08/31 COVID swab, result: detected 08/31 SARS-COV-2 LINEAGE b.1.617.2 08/31 SARS-COV-2 CLADE 21J DELTA
come down with COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (come down with COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (come down with COVID). At the time of the report, COVID-19 (come down with COVID) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Temp 102, chills, headache saw physician on Monday-said alternate Tylenol and ibuprofen. No definitive Dx.